PIK3CA and cancer: In human cancer, PIK3CA mutations are detected in DCIS [5], [6], [7] suggesting that PIK3CA mutation is an early event in the tumorigenic process and that, presumably, other mutational events are required to initiate progression to invasive carcinoma.